年龄相关性黄斑变性（AMD）：展望未来
Age-Related Macular Degeneration (AMD): A View to the Future.
作者信息
Miller Joan W, D'Anieri Lily L, Husain Deeba, Miller John B, Vavvas Demetrios G
机构信息
Retina Service, Department of Ophthalmology, Harvard Medical School, Massachusetts Eye and Ear, Boston, MA 02114, USA.
出版信息
J Clin Med. 2021 Mar 8;10(5):1124. doi: 10.3390/jcm10051124.
Abstract
Age-related macular degeneration (AMD) is the leading cause of blindness in people over age 50 worldwide, and the third leading cause of blindness overall [...].
摘要
年龄相关性黄斑变性（AMD）是全球50岁以上人群失明的主要原因，也是总体失明的第三大原因[...]。
相似文献
1
Age-Related Macular Degeneration (AMD): A View to the Future.年龄相关性黄斑变性（AMD）：展望未来
J Clin Med. 2021 Mar 8;10(5):1124. doi: 10.3390/jcm10051124.
2
Nanodiagnostics and Nanotherapeutics for age-related macular degeneration.用于年龄相关性黄斑变性的纳米诊断学和纳米治疗学。
J Control Release. 2021 Jan 10;329:1262-1282. doi: 10.1016/j.jconrel.2020.10.054. Epub 2020 Oct 29.
3
Age-related macular degeneration.年龄相关性黄斑变性。
Nat Rev Dis Primers. 2021 May 6;7(1):31. doi: 10.1038/s41572-021-00265-2.
4
Age-related macular degeneration: diagnosis and management.年龄相关性黄斑变性：诊断与管理
Br Med Bull. 2008;85:127-49. doi: 10.1093/bmb/ldn012.
5
Age-related macular degeneration: a leading cause of blindness.年龄相关性黄斑变性：失明的主要原因。
Med J Aust. 1996 Nov 18;165(10):561-4.
6
Anti-VEGF agents for age-related macular degeneration.抗血管内皮生长因子药物治疗年龄相关性黄斑变性。
Expert Opin Ther Pat. 2010 Jan;20(1):103-18. doi: 10.1517/13543770902762885.
7
The national and subnational prevalence and burden of age-related macular degeneration in China.中国年龄相关性黄斑变性的全国及各地区患病率和疾病负担
J Glob Health. 2017 Dec;7(2):020703. doi: 10.7189/jogh.07.020703.
8
The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences.美国年龄相关性黄斑变性的双生子研究：遗传和环境影响的相对作用。
Arch Ophthalmol. 2005 Mar;123(3):321-7. doi: 10.1001/archopht.123.3.321.
9
Macular dystrophies mimicking age-related macular degeneration.黄斑营养不良类似于年龄相关性黄斑变性。
Prog Retin Eye Res. 2014 Mar;39:23-57. doi: 10.1016/j.preteyeres.2013.11.001. Epub 2013 Nov 28.
10
Age-related macular degeneration.年龄相关性黄斑变性。
Adv Exp Med Biol. 2012;724:15-36. doi: 10.1007/978-1-4614-0653-2_2.
引用本文的文献
1
5α-Hydroxycostic acid inhibits choroidal neovascularization in rats through a dual signalling pathway mediated by VEGF and angiopoietin 2.5α-羟基皮质甾酮通过 VEGF 和血管生成素 2 双重信号通路抑制大鼠脉络膜新生血管。
Mol Med. 2023 Nov 1;29(1):151. doi: 10.1186/s10020-023-00674-x.
2
Pharmacokinetic and Target Engagement Measures of ANX007, an Anti-C1q Antibody Fragment, Following Intravitreal Administration in Nonhuman Primates.在非人灵长类动物中经玻璃体内给药后，抗 C1q 抗体片段 ANX007 的药代动力学和靶点结合度量。
Invest Ophthalmol Vis Sci. 2023 Feb 1;64(2):3. doi: 10.1167/iovs.64.2.3.
3
Development and Utilization of Corn Processing by-Products: A Review.玉米加工副产物的开发与利用：综述
Foods. 2022 Nov 18;11(22):3709. doi: 10.3390/foods11223709.
4
Characterization of Retinal Development in 13-Lined Ground Squirrels. characterization of retinal development in 13-lined ground squirrels.
Transl Vis Sci Technol. 2022 Nov 1;11(11):17. doi: 10.1167/tvst.11.11.17.
5
Necroptosis and Neuroinflammation in Retinal Degeneration.视网膜变性中的坏死性凋亡与神经炎症
Front Neurosci. 2022 Jun 29;16:911430. doi: 10.3389/fnins.2022.911430. eCollection 2022.
6
Novel Epigenetic Clock Biomarkers of Age-Related Macular Degeneration.年龄相关性黄斑变性的新型表观遗传时钟生物标志物。
Front Med (Lausanne). 2022 Jun 16;9:856853. doi: 10.3389/fmed.2022.856853. eCollection 2022.
7
Microglia: Key Players in Retinal Ageing and Neurodegeneration.小胶质细胞：视网膜衰老和神经退行性变的关键参与者。
Front Cell Neurosci. 2022 Mar 17;16:804782. doi: 10.3389/fncel.2022.804782. eCollection 2022.
本文引用的文献
1
3-D retina organoids: Building platforms for therapies of the future.三维视网膜类器官：构建未来治疗的平台。
Cell Med. 2018 Jun 8;10:2155179018773758. doi: 10.1177/2155179018773758. eCollection 2018.
2
A systems biology approach towards understanding and treating non-neovascular age-related macular degeneration.一种系统生物学方法，用于理解和治疗非新生血管性年龄相关性黄斑变性。
Nat Commun. 2019 Jul 26;10(1):3347. doi: 10.1038/s41467-019-11262-1.
3
Evaluation of Transplanted Autologous Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium in Exudative Age-Related Macular Degeneration.自体诱导多能干细胞来源的视网膜色素上皮细胞移植治疗渗出性年龄相关性黄斑变性的评估
Ophthalmol Retina. 2019 Oct;3(10):850-859. doi: 10.1016/j.oret.2019.04.021. Epub 2019 Apr 26.
4
Advances in Age-related Macular Degeneration Understanding and Therapy.年龄相关性黄斑变性的认识与治疗进展
US Ophthalmic Rev. 2017 Fall;10(2):119-130. doi: 10.17925/USOR.2017.10.02.119.
5
Chemically-induced photoreceptor degeneration and protection in mouse iPSC-derived three-dimensional retinal organoids.化学诱导的小鼠诱导多能干细胞来源的三维视网膜类器官中的光感受器变性与保护
Stem Cell Res. 2017 Oct;24:94-101. doi: 10.1016/j.scr.2017.08.018. Epub 2017 Aug 24.
6
Activated Retinal Pigment Epithelium, an Optical Coherence Tomography Biomarker for Progression in Age-Related Macular Degeneration.活化视网膜色素上皮，一种用于年龄相关性黄斑变性进展的光学相干断层扫描生物标志物。
Invest Ophthalmol Vis Sci. 2017 May 1;58(6):BIO211-BIO226. doi: 10.1167/iovs.17-21872.
7
Autologous Induced Stem-Cell-Derived Retinal Cells for Macular Degeneration.自体诱导干细胞衍生的视网膜细胞治疗黄斑变性。
N Engl J Med. 2017 Mar 16;376(11):1038-1046. doi: 10.1056/NEJMoa1608368.
8
Histologic and Optical Coherence Tomographic Correlates in Drusenoid Pigment Epithelium Detachment in Age-Related Macular Degeneration.年龄相关性黄斑变性中玻璃膜疣样色素上皮脱离的组织学与光学相干断层扫描相关性
Ophthalmology. 2017 May;124(5):644-656. doi: 10.1016/j.ophtha.2016.12.034. Epub 2017 Jan 30.
9
Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis.全球与年龄相关的黄斑变性患病率及 2020 与 2040 年疾病负担预测：系统回顾和荟萃分析。
Lancet Glob Health. 2014 Feb;2(2):e106-16. doi: 10.1016/S2214-109X(13)70145-1. Epub 2014 Jan 3.
10
Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.叶黄素+玉米黄质和欧米伽-3 脂肪酸治疗年龄相关性黄斑变性：年龄相关性眼病研究 2（AREDS2）随机临床试验。
JAMA. 2013 May 15;309(19):2005-15. doi: 10.1001/jama.2013.4997.
Zotero 插件